Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum
March 16 2022 - 4:05PM
Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics
contract development and manufacturing organization (CDMO) working
to improve patient lives by providing high quality services to
biotechnology and pharmaceutical companies, today announced that
the company will participate in the KeyBanc Capital Markets Life
Sciences & MedTech Forum. Nick Green, president and chief
executive officer of Avid Bioservices, will be the featured speaker
in a fireside chat at the conference, which will take place March
22-23, 2022 in a virtual format.
Details of the company’s participation are as follows:
- KeyBanc Capital Markets
Life Sciences & MedTech Forum Conference Date:
March 22-23, 2022 Fireside Chat Time/Date: 1:30 - 2:05 p.m. Eastern
on Wednesday, March 23, 2022 Format: Virtual Conference; webcast
available
To listen to the live webcast of the KeyBanc
fireside chat, or access the archived webcast, please visit:
http://ir.avidbio.com/investor-events.
About Avid
Bioservices, Inc.
Avid Bioservices (NASDAQ:CDMO), an S&P
SmallCap 600 company, is a dedicated contract development and
manufacturing organization (CDMO) focused on development and CGMP
manufacturing of biologics. The company provides a comprehensive
range of process development, CGMP clinical and commercial
manufacturing services for the biotechnology and biopharmaceutical
industries. With 28 years of experience producing monoclonal
antibodies and recombinant proteins, Avid's services include CGMP
clinical and commercial drug substance manufacturing, bulk
packaging, release and stability testing and regulatory submissions
support. For early-stage programs the company provides a variety of
process development activities, including upstream and downstream
development and optimization, analytical methods development,
testing and characterization. The scope of our services ranges
from standalone process development projects to full development
and manufacturing programs through commercialization.
www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2023 to Apr 2024